Chemistry:CHF-1024
From HandWiki
CHF-1024, also known as 5,6-dihydroxy-2-methylaminotetralin, is a dopamine D2 receptor agonist and α2-adrenergic receptor agonist of the 2-aminotetralin family.[1][2] It is a cyclized phenethylamine analogue of the neurotransmitter dopamine.[1] The drug is the active form of nolomirole (CHF-1035), a prodrug of CHF-1024 and the N,N-diisobutyryl diester of the compound.[1][2] Nolomirole was investigated for the treatment of heart failure but was never marketed.[1][2]
See also
- Chiesi Farmaceutici
- Nolomirole
- Cyclized phenethylamine
- Rotigotine
- 5-OH-DPAT
- 7-OH-DPAT
- Carmoxirole
References
- ↑ 1.0 1.1 1.2 1.3 "Nolomirole Hydrochloride". Drugs of the Future 26 (11): 1046. 2001. doi:10.1358/dof.2001.026.11.642071. http://access.portico.org/stable?au=pjbf78xdt6c. Retrieved 19 June 2025.
- ↑ 2.0 2.1 2.2 "Novel pharmacological treatments for heart failure". Expert Opinion on Investigational Drugs 12 (11): 1791–1801. November 2003. doi:10.1517/13543784.12.11.1791. PMID 14585055.
| α1 |
|
|---|---|
| α2 |
|
| β |
|
| Phenethylamines |
|
|---|---|
| Amphetamines |
|
| Phentermines |
|
| Cathinones |
|
| Phenylisobutylamines | |
| Phenylalkylpyrrolidines | |
| Catecholamines (and close relatives) |
|
| Miscellaneous |
|
0.00 ![]() ![]() ![]() ![]() (0 votes) |
